Sequence analysis for detection of drug resistance in Mycobacterium tuberculosis complex isolates from the Central Region of Cameroon
Authors:
- Emmanuel Mouafo TekwuETEmmanuel Mouafo Tekwu
- Larissa Kamgue SidzeLSLarissa Kamgue Sidze
- Jean-Paul Assam AssamJAJean-Paul Assam Assam
- Jean-Claude TedomJTJean-Claude Tedom
- Serges TchatchouangSTSerges Tchatchouang
- Gaëlle Guiewi MakafeGMGaëlle Guiewi Makafe
- Anne-Laure Tchokote WetewaleAWAnne-Laure Tchokote Wetewale
- Christopher KuabanCKChristopher Kuaban
- Sara EyangohSESara Eyangoh
- Francine NtoumiFNFrancine Ntoumi
- Véronique N Penlap BengVBVéronique N Penlap Beng
- Matthias FrankMFMatthias Frank
Open Access
- 3 May 2014
- journal article
- research article
- Published by Springer Nature in BMC Microbiology
- Vol. 14 (1) , 1-10
Abstract
The potential of genetic testing to rapidly diagnose drug resistance has lead to the development of new diagnostic assays. However, prior to implementation in a given setting, the association of specific mutations with specific drug resistance phenotypes should be evaluated. The purpose of this study was to evaluate molecular markers in predicting drug resistance in the Central Region of Cameroon. From April 2010 and March 2011, 725 smear positive pulmonary tuberculosis patients were enrolled and all positive cultures were tested for drug susceptibility. A total of 63 drug resistant and 100 drug sensitive Mycobacterium tuberculosis complex clinical isolates were screened for genetic mutations in katG, inhA, ahpC, rpoB, rpsL, rrs, gidB and embCAB loci using DNA sequencing. Of the 44 isoniazid resistant (INHR) isolates (24 high level, 1 μg/ml and 20 low level, 0.2 μg/ml), 73% (32/44) carried the katG315 and/or the -15 inhA promoter mutations. Of the 24 high level INHR, 17 (70.8%) harbored katG315 mutation, 1 a point mutation (-15C → T) in the inhA promoter and 6 were (25.0%) wild types. Thus, for INHR high level detection, katG315 mutation had a specificity and a sensitivity of 100% and 70.8% respectively. Of the 20 low level INHR, 10 (50.0%) had a -15C → T mutation in the inhA promoter region, and 1 (2.2%) a -32G → A mutation in the ahpC promoter region. All of the 7 rifampicin resistant (RIFR) isolates carried mutations in the rpoB gene (at codons Ser531Leu (71.4%), His526Asp (14.3%), and Asp516Val (14.3%)). Of the 27 streptomycin resistant (SMR) isolates, 7 carried mutations at the rpsL and the gidB genes. 1 of the 2 ethambutol resistant (EMB R) isolates displayed a mutation in embB gene. This study provided the first molecular investigation assessing the correlation of phenotypic to genotypic characteristics on MTB isolates from the Central Region of Cameroon using DNA sequencing. Mutations on rpoB, katG315 and -15 point mutations in inhA promoter loci could be used as markers for RIF and INH -resistance detection respectively.Keywords
This publication has 50 references indexed in Scilit:
- Tuberculosis diagnosis in resource-limited settings: Clinical use of GeneXpert in the diagnosis of smear-negative PTB: a case reportAfrican Health Sciences, 2013
- Molecular Detection of Mutations Associated with First- and Second-Line Drug Resistance Compared with Conventional Drug Susceptibility Testing of Mycobacterium tuberculosisAntimicrobial Agents and Chemotherapy, 2011
- Increasing Drug Resistance in Extensively Drug-Resistant Tuberculosis, South AfricaEmerging Infectious Diseases, 2011
- Rapid Molecular Detection of Tuberculosis and Rifampin ResistanceNew England Journal of Medicine, 2010
- Role of embCAB gene mutations in ethambutol resistance in Mycobacterium tuberculosis isolates from IndiaInternational Journal of Antimicrobial Agents, 2009
- Correlations of mutations in katG, oxyR-ahpC and inhA genes and in vitro susceptibility in Mycobacterium tuberculosisclinical strains segregated by spoligotype families from tuberculosis prevalent countries in South AmericaBMC Microbiology, 2009
- Genetic evaluation of relationship between mutations in rpoB and resistance of Mycobacterium tuberculosis to rifampinBMC Microbiology, 2009
- Characterization of Tunisian Mycobacterium tuberculosis Rifampin-Resistant Clinical IsolatesJournal of Clinical Microbiology, 2007
- Significance of Mutations in embB Codon 306 for Prediction of Ethambutol Resistance in Clinical Mycobacterium tuberculosis IsolatesAntimicrobial Agents and Chemotherapy, 2006
- Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequenceNature, 1998